Assorted News from the Last Week:
A systematic review and meta-analysis of 23 randomized clinical trials showed a cannabinoids used for medical purposes in children and adolescents come with a risk of adverse events. Novel treatment regimen yields promising response in advanced-phase chronic myeloid leukemia. Vaccine experts report positive results on Phase 1 trial of personalized vaccine for lymphoplasmacytic lymphoma. Non-Hispanic black children experience poorer post-relapse survival outcomes than white children with nonmetastatic osteosarcoma. AACR report highlights improvements in outcomes for children and adolescents.Congressman Michael McCaul hosted the 15th Annual Childhood Cancer Summit last week.
Upcoming Webinars, Online Opportunities, and Meetings:
The NCI Office of Data Sharing (ODS) is excited to be hosting the second Annual Data Sharing Symposium Driving Cancer Advances through Impactful Research, a free hybrid event open to all on October 15th and 16th on NIH’s Bethesda campus or online! Register here.
56th Congress of the International Society of Paediatric Oncology (SIOP 2024), which will take place in Honolulu, Hawaii, USA | October 17-20, 2024. Registration is open and anyone who registers before July 17, 2024 can take advantage of the discounted rates.
The Food and Drug Administration (FDA) will hold a virtual Patient Engagement Advisory Committee (the Committee) meeting on Patient-Centered Informed Consent in Clinical Study on October 30 from 10:00-5:00 ET. Click here for more information and to register .Past Recordings:
Six-month-old Atef Tayeh from Gaza was diagnosed with cancer just a few months into his life but he can’t get treatment there or travel abroad due to Israel’s war and its closure of the border.Take Action:
Visit the recently launched Childhood Cancer Hub, a comprehensive directory of resources for childhood cancer patients and their families. Please share with your network to help our families in need at every phase of their journey. childhoodcancerhub.org The FDA and CTTI announced the call for applications for new members of the Patient Engagement Collaborative (PEC). The PEC is an ongoing, shared forum in which the patient community (PEC members), FDA, and CTTI discuss a variety of topics such as improving communication, education, and patient engagement related to medical product regulation. NIH recently announced a Request for Information to gather community input on additional proposed actions to accelerate the career transition of postdoc scholars into thriving biomedical research careers. Please note that feedback will be accepted electronically until October 23, 2024. See the Open Mike Blog for additional information.CAC2 Innovation Council Recommendation: “Introduction to Pediatric Cancer & Mental Health” Training Course
Overview of the Opportunity: “Introduction to Pediatric Cancer & Mental Health” training course is a comprehensive program designed for providers, professionals, and support systems seeking to enhance their understanding of the intersection between pediatric cancer and mental health. CAC2 members are asked to share details about this specialized course (approved by The National Association of Social Work for 2.5 CE credits) with childhood cancer providers and professionals in their networks.